Jacques Camerlo
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Oncology top 10%
- Cancer survivorship and care
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Neutropenia and Cancer Infections
Papers in
- Oncology 30
- Neutropenia and Cancer Infections 10
- Cancer Treatment and Pharmacology 9
- Cancer survivorship and care 6
- Cancer Cells and Metastasis 3
- Hematology 15
- Hematopoietic Stem Cell Transplantation 9
- Co-authors
- Patrice Viens (33 shared papers)D Maraninchi (37 shared papers)Dominique Genre (19 shared papers)Gwénaëlle Gravis (23 shared papers)M. Resbeut (8 shared papers)François Bertucci (11 shared papers)Didier Blaise (15 shared papers)Norbert Vey (13 shared papers)
In The Last Decade
Jacques Camerlo
49 papers receiving 898 citations
Peers
Comparison fields: 5 of 90
- Hematology 212
- Oncology 448
- Cancer Research 190
- Genetics 105
- Pathology and Forensic Medicine 144
Countries citing papers authored by Jacques Camerlo
This map shows the geographic impact of Jacques Camerlo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Camerlo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Camerlo more than expected).
Fields of papers citing papers by Jacques Camerlo
This network shows the impact of papers produced by Jacques Camerlo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Camerlo. The network helps show where Jacques Camerlo may publish in the future.
Co-authors
The 25 scholars most cited alongside Jacques Camerlo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 144 | |
| 2 | 1997 | 68 | |
| 3 | 2003 | 57 | |
| 4 | 2002 | 52 | |
| 5 | 2017 | 45 | |
| 6 | 2000 | 44 | |
| 7 | 1996 | 43 | |
| 8 | 1997 | 37 | |
| 9 | 1999 | 32 | |
| 10 | 1994 | 26 | |
| 11 | 2011 | 26 | |
| 12 | 1995 | 25 | |
| 13 | Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): a feasibility trial in 15 patients. | 1991 | 25 |
| 14 | 1998 | 24 | |
| 15 | Delayed administration of granulocyte colony-stimulating factor after autologous bone marrow transplantation: effect on granulocyte recovery. | 1994 | 22 |
| 16 | 2004 | 18 | |
| 17 | 1999 | 17 | |
| 18 | 1986 | 17 | |
| 19 | 1996 | 15 | |
| 20 | 2003 | 15 |
About Jacques Camerlo
Jacques Camerlo is a scholar working on Oncology, Hematology, Genetics, Cancer Research and Molecular Biology, having authored 50 papers that have together received 932 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (10 papers), Cancer Treatment and Pharmacology (9 papers), Hematopoietic Stem Cell Transplantation (9 papers), Chronic Lymphocytic Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (8 papers), Breast Cancer Treatment Studies (6 papers), Cancer survivorship and care (6 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Hematology (212 citations), Oncology (448 citations), Cancer Research (190 citations), Genetics (105 citations) and Pathology and Forensic Medicine (144 citations). Jacques Camerlo has collaborated with scholars based in France and Armenia. Frequent co-authors include Patrice Viens, D Maraninchi, Dominique Genre, Gwénaëlle Gravis, M. Resbeut, François Bertucci, Didier Blaise, Norbert Vey, Réda Bouabdallah and Christel Protière. Their work appears in journals such as Cancer, Bone Marrow Transplantation, British Journal of Haematology, European Journal of Cancer and Supportive Care in Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.